HEKMA brings clarity, connection, and calm to living with serious illness, from your medication schedule to what's actually happening inside the clinical study you enrolled in.
The Uncomfortable Truth
We built HEKMA to fix four specific failures that harm patients every single day.
0%
of trial participants never learn their study's outcome
0%
of patients miss doses due to confusion, not intent
6.2 yrs
average time from diagnosis to finding the right trial
1 in 3
patients feel their care team doesn't truly know them
None of these are acceptable. HEKMA was built to change all four.
Designed with input from patients living with cancer, rare diseases, and chronic conditions. Every feature earns its place.
Log mood, energy, photos, and notes every day. Every entry becomes a story your care team actually understands.
Learn moreHEKMA connects securely to your electronic health records and organises your fragmented medical history into one clear, chronological picture you can share with study teams in a single click.
Learn moreYour profile is matched against every eligible trial, and study teams looking for participants like you can find you too. You are never invisible to research that could change your life.
Learn moreYour profile. Every eligible trial. Plain English, not a 40-page protocol. Matched weekly and pushed to you as they open.
Learn moreOne calendar for study visits and personal care. Pre-visit checklists. Telehealth links. Never show up unprepared again.
Learn moreBody map, severity scale, AI pattern insights. Weeks of data that speak for you before you even open your mouth.
Learn moreSet SMART goals: activity, sleep, adherence. Progress auto-tracks from connected devices. No manual math.
Learn moreToggle between beginner and deep-dive. Tap any clinical term for a plain-language definition. Learning at your pace.
Learn moreOur Signature Feature
Most patients who join clinical studies are left in the dark after enrollment. No updates. No context. No idea if their contribution mattered.
HEKMA's live study feed gives you phase-by-phase transparency, plain-English updates from your study team, and a real-time window into your trial's progress, in words that actually make sense.
Study NCT04521738 · Phase II
Venetoclax in Relapsed AML
Screening
Completed Jan 14
Baseline
Completed Feb 3
Treatment
CurrentCycle 3 of 6 — ongoing
Follow-up
Estimated Aug 2025
Results
Estimated Q1 2026
Latest update
· 3 days ago"Interim analysis shows promising response rates in your cohort. No safety concerns identified. Continue scheduled visits."
Plain-language summary by HEKMA AI
Medication Adherence
Complex regimens, seven medications, different timings, some with food, some without, are a silent crisis for patients. HEKMA makes adherence effortless, and tracks compliance for your study team only with your explicit consent.
One-tap logging
Mark a dose taken in 2 seconds from your lock screen notification.
Refill predictor
Know your next refill date before you run out, automatically.
Caregiver alerts
Optional: family is notified if 2+ consecutive doses are missed.
Study compliance
Investigational drug adherence shared with sponsors, only with your consent.
Connected Health
HEKMA unifies data from your wearables and Bluetooth-enabled medical devices into a single, meaningful health picture your care team can actually use.
Continuous monitoring
Heart rate, SpO₂, HRV, sleep quality, stored as FHIR R4 observations and shared with your care team in real time.
You control everything
Per-device, per-data-type permissions. Grant access to your doctor. Revoke in seconds. No hidden data pipelines.
Clinically meaningful
Not just numbers, patterns. Correlations between device data, symptoms, medications, and your study visits surface automatically.
No more searching through hundreds of listings. HEKMA matches your profile to every open trial globally, instantly.
Answer a few questions about your condition, history, and location. Takes under 3 minutes.
Our AI scans thousands of open trials and surfaces the ones that fit your exact profile.
Reach out to trial coordinators. We handle introductions so you can focus on your health.
HEKMA AI Match
Your matched trials
Type 2 Diabetes
Phase III • New York, NY
match
Epilepsy
Phase II • Boston, MA
match
Rare Genetics
Phase I • Remote
match
Scanning 4,200+ active trials...
For Patient Advocacy Groups
HEKMA's PAG workspace gives advocacy organizations the infrastructure to support, engage, and amplify their patient communities, without spreadsheets, email chains, or compliance headaches.
Start Today, It's Free
Join thousands of patients and advocacy groups who've taken back ownership of their health journey.
No credit card. No commitments. HIPAA-compliant from day one.